从 2022 年起,根据第五版《世界卫生组织血淋巴肿瘤分类》概述组织细胞和树突状细胞疾病。

Q4 Medicine Klinicka Onkologie Pub Date : 2024-01-01 DOI:10.48095/ccko2024164
Z Adam, M Hermanová, T Horváth, L Pour, S Ševčíková, K Starý, M Dastych, Z Řehák, Z Adamová, Z Král
{"title":"从 2022 年起,根据第五版《世界卫生组织血淋巴肿瘤分类》概述组织细胞和树突状细胞疾病。","authors":"Z Adam, M Hermanová, T Horváth, L Pour, S Ševčíková, K Starý, M Dastych, Z Řehák, Z Adamová, Z Král","doi":"10.48095/ccko2024164","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Histiocytoses are rare disorders characterized by the accumulation of macrophages, dendritic cells, or monocyte-derived cells in various tissues and organs of children and adults, with a wide range of clinical manifestations, presentations, and histology. The histiocytoses are classified according to the WHO Classification, the last version of which was published in 2022, or according to the Histiocyte Society Classification, with the last version published in 2016.</p><p><strong>Purpose: </strong>This text provides an overview of histiocytoses as described in the WHO Classification 2022.</p>","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Overview of histiocytic and dendritic disorders by the 5th version of WHO Classifi cation of Hematolymphoid Tumours from 2022.\",\"authors\":\"Z Adam, M Hermanová, T Horváth, L Pour, S Ševčíková, K Starý, M Dastych, Z Řehák, Z Adamová, Z Král\",\"doi\":\"10.48095/ccko2024164\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Histiocytoses are rare disorders characterized by the accumulation of macrophages, dendritic cells, or monocyte-derived cells in various tissues and organs of children and adults, with a wide range of clinical manifestations, presentations, and histology. The histiocytoses are classified according to the WHO Classification, the last version of which was published in 2022, or according to the Histiocyte Society Classification, with the last version published in 2016.</p><p><strong>Purpose: </strong>This text provides an overview of histiocytoses as described in the WHO Classification 2022.</p>\",\"PeriodicalId\":35565,\"journal\":{\"name\":\"Klinicka Onkologie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinicka Onkologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.48095/ccko2024164\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicka Onkologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48095/ccko2024164","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景:组织细胞增多症是一种罕见疾病,其特征是儿童和成人的各种组织和器官中出现巨噬细胞、树突状细胞或单核细胞衍生细胞的聚集,临床表现、表现和组织学各不相同。组织细胞增生症根据世界卫生组织的分类进行分类,其最新版本发布于2022年,或根据组织细胞学会的分类进行分类,其最新版本发布于2016年。目的:本文概述了世界卫生组织2022年分类中描述的组织细胞增生症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Overview of histiocytic and dendritic disorders by the 5th version of WHO Classifi cation of Hematolymphoid Tumours from 2022.

Background: Histiocytoses are rare disorders characterized by the accumulation of macrophages, dendritic cells, or monocyte-derived cells in various tissues and organs of children and adults, with a wide range of clinical manifestations, presentations, and histology. The histiocytoses are classified according to the WHO Classification, the last version of which was published in 2022, or according to the Histiocyte Society Classification, with the last version published in 2016.

Purpose: This text provides an overview of histiocytoses as described in the WHO Classification 2022.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Klinicka Onkologie
Klinicka Onkologie Medicine-Oncology
CiteScore
1.00
自引率
0.00%
发文量
37
期刊最新文献
Potential application of body fluids autofluorescence in the non-invasive diagnosis of endometrial cancer Factors influencing overall survival and GvHD development after allogeneic hematopoietic stem cell transplantation – single centre experience Prostate cancer invasion is promoted by the miR-96-5p-induced NDRG1 deficiency through NF-κB regulation Tebentafusp in the treatment of metastatic uveal melanoma – the first patient treated in the Czech Republic Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab – a non-interventional observational study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1